We found that the expression of PARP1 was higher in lung cancer–MSCs, and the SFPQ knocking down reduced the levels of PARP1 and γ2HAX in NSC lung cancer -MSCs (Figures 3A, B). The gene discussed is PARP1; the disease is lung cancer.